Cristina Smolenschi - Publications

Third-line treatment of biliary tract cancers in a real-life setting.

Journal: ESMO gastrointestinal oncology

Published: August 12, 2026

Ivonescimab in combination with chemotherapy in advanced or metastatic gastric cancer (GC) or esophagogastric junction cancer (EGJC): The UCGI 52 - GRACIE trial.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: July 24, 2026

Antiangiogenic therapies in gastric cancer: future directions for 2026 and beyond: an UNICANCER gastrointestinal group (UCGI) perspective.

Journal: Cancer treatment reviews

Published: May 04, 2026

Clinical and molecular characteristics of early-onset pancreatic and biliary cancers.

Journal: ESMO gastrointestinal oncology

Published: April 17, 2026

Outcomes of patients treated by FGFR inhibitors according to alteration types: An agnostic monocentric retrospective cohort.

Journal: European journal of cancer (Oxford, England : 1990)

Published: April 17, 2026

Claudin 18.2 blockade and gastric toxicity: Insights from two European cases with advanced gastric adenocarcinoma.

Journal: European journal of cancer (Oxford, England : 1990)

Published: April 14, 2026

Metastatic or unresectable recurrent anal canal cancer: Therapeutic approaches and emerging perspectives

Journal: Bulletin du cancer

Published: March 30, 2026

Exploring the diversity of rare exocrine pancreatic cancers: A histo-molecular mapping of a French tertiary-centre cohort.

Journal: European journal of cancer (Oxford, England : 1990)

Published: March 26, 2026

Integrating tumor volumetry and liquid biopsy: a New model to define prognosis in advanced pancreatic ductal adenocarcinoma.

Journal: European journal of cancer (Oxford, England : 1990)

Published: March 01, 2026

The increasing burden of early-onset pancreatic and biliary tract cancers: a review of risk factors.

Journal: ESMO gastrointestinal oncology

Published: February 06, 2026

Intra-arterial hepatic chemotherapy in metastatic colorectal cancer: differences between oxaliplatin-naive versus oxaliplatin-pretreated patients.

Journal: ESMO gastrointestinal oncology

Published: February 06, 2026

Anti-Epidermal Growth Factor Receptor Therapy in EGFR-Amplified Esophagogastric Cancers: An Underestimated Efficacy.

Journal: JCO precision oncology

Published: December 10, 2025